102 related articles for article (PubMed ID: 25667446)
1. Detection of circulating tumor cells in high-risk endometrial cancer.
Bogani G; Liu MC; Dowdy SC; Cliby WA; Kerr SE; Kalli KR; Kipp BR; Halling KC; Campion MB; Mariani A
Anticancer Res; 2015 Feb; 35(2):683-7. PubMed ID: 25667446
[TBL] [Abstract][Full Text] [Related]
2. Detection of circulating tumour cells may add value in endometrial cancer management.
Ni T; Sun X; Shan B; Wang J; Liu Y; Gu SL; Wang YD
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():1-4. PubMed ID: 27756035
[TBL] [Abstract][Full Text] [Related]
3. Hematogenous dissemination in corpus cancer.
Mariani A; Webb MJ; Keeney GL; Calori G; Podratz KC
Gynecol Oncol; 2001 Feb; 80(2):233-8. PubMed ID: 11161865
[TBL] [Abstract][Full Text] [Related]
4. Correlation Between Disease Stage and the Presence of Viable Circulating Tumor Cells in Endometrial Cancer.
Kiss I; Kolostova K; Matkowski R; Jędryka M; Czekański A; Pavlasek J; Bobek V
Anticancer Res; 2018 May; 38(5):2983-2987. PubMed ID: 29715128
[TBL] [Abstract][Full Text] [Related]
5. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
Cai QQ; Huang HQ; Lin TX; Jiang WQ
Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
[TBL] [Abstract][Full Text] [Related]
6. Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection.
Uen YH; Lu CY; Tsai HL; Yu FJ; Huang MY; Cheng TL; Lin SR; Wang JY
Ann Surg Oncol; 2008 Aug; 15(8):2120-8. PubMed ID: 18481151
[TBL] [Abstract][Full Text] [Related]
7. [The study of associations between circulating tumor cells and clinicopathologic characteristics in axillary lymph node positive primary breast cancer].
Zhou Y; Ouyang T; Wang T; Xie Y; Fan Z; Fan T; Li J
Zhonghua Wai Ke Za Zhi; 2014 Jun; 52(6):420-4. PubMed ID: 25219556
[TBL] [Abstract][Full Text] [Related]
8. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
Ivanov I
Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
[TBL] [Abstract][Full Text] [Related]
9. Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer.
AlHilli MM; Podratz KC; Dowdy SC; Bakkum-Gamez JN; Weaver AL; McGree ME; Keeney GL; Cliby WA; Mariani A
Gynecol Oncol; 2013 Oct; 131(1):103-8. PubMed ID: 23845691
[TBL] [Abstract][Full Text] [Related]
10. Enumeration and Molecular Characterisation of Circulating Tumour Cells in Endometrial Cancer.
Lemech CR; Ensell L; Paterson JC; Eminowicz G; Lowe H; Arora R; Arkenau HT; Widschwendter M; MacDonald N; Olaitan A; Mould T; Meyer T; Hartley J; Mitra A; Ledermann JA; McCormack M; Kristeleit RS
Oncology; 2016; 91(1):48-54. PubMed ID: 27256106
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A
Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790
[TBL] [Abstract][Full Text] [Related]
12. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
Krishnamurthy S; Cristofanilli M; Singh B; Reuben J; Gao H; Cohen EN; Andreopoulou E; Hall CS; Lodhi A; Jackson S; Lucci A
Cancer; 2010 Jul; 116(14):3330-7. PubMed ID: 20564098
[TBL] [Abstract][Full Text] [Related]
13. Does the type of surgery for early-stage endometrial cancer affect the rate of reported lymphovascular space invasion in final pathology specimens?
Momeni M; Kolev V; Cardenas-Goicoechea J; Getrajdman J; Fishman D; Chuang L; Kalir T; Rahaman J; Zakashansky K
Am J Obstet Gynecol; 2013 Jan; 208(1):71.e1-6. PubMed ID: 23099190
[TBL] [Abstract][Full Text] [Related]
14. Relevance of sentinel lymph node procedure for patients with high-risk endometrial cancer.
Naoura I; Canlorbe G; Bendifallah S; Ballester M; Daraï E
Gynecol Oncol; 2015 Jan; 136(1):60-4. PubMed ID: 25449312
[TBL] [Abstract][Full Text] [Related]
15. Risk factors that mitigate the role of paraaortic lymphadenectomy in uterine endometrioid cancer.
Kumar S; Mariani A; Bakkum-Gamez JN; Weaver AL; McGree ME; Keeney GL; Cliby WA; Podratz KC; Dowdy SC
Gynecol Oncol; 2013 Sep; 130(3):441-5. PubMed ID: 23747331
[TBL] [Abstract][Full Text] [Related]
16. Immunomagnetic quantification of circulating tumoral cells in patients with prostate cancer: clinical and pathological correlation.
Resel Folkersma L; Olivier Gómez C; San José Manso L; Veganzones de Castro S; Galante Romo I; Vidaurreta Lázaro M; de la Orden GV; Arroyo Fernández M; Díaz Rubio E; Silmi Moyano A; Maestro de Las Casas MA
Arch Esp Urol; 2010; 63(1):23-31. PubMed ID: 20157216
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors in diagnosed endometrial cancers determining the type of radical surgery].
Ivanov S; Tomov S
Akush Ginekol (Sofiia); 2009; 48(3):14-9. PubMed ID: 20198758
[TBL] [Abstract][Full Text] [Related]
18. Mucinous differentiation does not impact stage or risk of recurrence among patients with grade 1, endometrioid type, endometrial carcinoma.
Worley MJ; Davis M; Berhie SH; Muto MG; Feltmate CM; Berkowitz RS; Horowitz NS; Campos SM
Gynecol Oncol; 2014 Oct; 135(1):54-7. PubMed ID: 25088333
[TBL] [Abstract][Full Text] [Related]
19. A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients.
Kim SJ; Masago A; Tamaki Y; Akazawa K; Tsukamoto F; Sato J; Ozawa T; Tsujino Y; Noguchi S
Breast Cancer Res Treat; 2011 Aug; 128(3):765-73. PubMed ID: 21630023
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three distinct methods for the detection of circulating tumor cells in colorectal cancer patients.
Gervasoni A; Sandri MT; Nascimbeni R; Zorzino L; Cassatella MC; Baglioni L; Panigara S; Gervasi M; Di Lorenzo D; Parolini O
Oncol Rep; 2011 Jun; 25(6):1669-703. PubMed ID: 21455578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
